Company / Current Liabilities
ImageneBio, Inc. Current Liabilities History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$11.2M
FY2025
5-year range
$10.8M / $27.2M
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities returned to growth in FY2025 after 3 years of decline, reaching $11M.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of -19.5%.
Improved from $14M to $11M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -19.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -19.5%, indicating a declining trend.
- In FY2025, current liabilities increased 4.2% year-over-year.
- Peak current liabilities was recorded in FY2021.
- Lowest current liabilities in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.2M | +4.2% |
| FY2024 | $10.8M | -24.1% |
| FY2023 | $14.2M | -33.9% |
| FY2022 | $21.5M | -20.9% |
| FY2021 | $27.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026